NCT07206719

Brief Summary

This was a prospective study. The study period was from January 2022 to July 2025. The study included 30 patients suffering from combined fecal and urinary incontinence submitted for concurrent Malone Antigrade continent Enema and Mitrofanoff procedures and evaluated regarding intraoperative difficulties, post-operative complications, functional results and patient's quality of live improvements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 22, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 22, 2025

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

September 26, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

3.6 years

First QC Date

September 26, 2025

Last Update Submit

September 26, 2025

Conditions

Keywords

Urinary incontinenceFecal incontinenceQuality of lifeMitrofanoff procedureMalone procedure

Outcome Measures

Primary Outcomes (1)

  • Surgical Outcomes

    Complication rate 1-Early as Occurrence of leak, abscess formation, intestinal obstruction, appendicular necrosis, fecal and urinary fistula formation. 2\. Late as Stricture formation and requirement of secondary procedures as dribbling of urine through the urethra or soiling of stool

    6 months

Secondary Outcomes (1)

  • Patients Quality Of Life post operatively

    6 months

Study Arms (1)

MACE and Malone

EXPERIMENTAL

patients suffering from combined fecal and urinary incontinence due to neuropathic etiology, after failure of all trials of non-surgical managements. They submitted for surgical management by concurrent Malone Antegrade Continent Enema (MACE) and Mitrofanoff procedures at the same operative sitting

Procedure: Malone Antegrade Continent Enema (MACE) and Mitrofanoff procedures

Interventions

* MACE Split appendix procedure: division of appendix into two segments, so making Mitrofanoff procedure by the distal appendicular segment and Malone procedure by proximal appendicular segment. * MACE Colonic flap Neoappendecosotomy procedure: creating the colonic flap from the ascending colon, tubularization done. The tip of the neo-appendix was spatulated and sutured with the triangular skin flap of umbilicus, then the silicon catheter in place passing through the neo appendix into the colon * Mitrofanoff procedure: The appendix was mobilized with its mesentery. The tip of the appendix was incised and a 10-12Fr feeding tube was inserted to confirm patency. Then Opening of the urinary bladder was done. The distal end of the appendix was then inserted into the bladder in a submucosal tunnel. The distal opening of the appendix was sutured to the inner bladder wall and mucosa using absorbable sutures.

MACE and Malone

Eligibility Criteria

Age5 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • all patients suffering from combined fecal and urinary incontinence due to neuropathic etiology
  • failure of all trials of non-surgical managements

You may not qualify if:

  • The patients responding to medical treatments,
  • patients with previous appendectomy,
  • patients with marked reduction of bladder capacity,
  • patients with Brain affection (Cerebral palsy, etc..)
  • and patients with isolated fecal or urinary incontinence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mohammad Daboos

Cairo, 115678, Egypt

Location

MeSH Terms

Conditions

Fecal IncontinenceUrinary Incontinence

Interventions

omega-Chloroacetophenone

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetophenonesKetonesOrganic Chemicals

Study Officials

  • Mohammad Daboos, prof

    Al-Azhar University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
surgical management by concurrent Malone Antigrade Continent Enema (MACE) and Mitrofanoff procedures at the same operative sitting, for patients suffered from combined fecal and urinary incontinence due to neuropathic etiology.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: MACE Split appendix procedure: MACE Colonic flap Neoappendecosotomy procedure Mitrofanoff procedure:
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant professor of pediatric surgery, Pediatric Surgery Department, Al-Azhar University.

Study Record Dates

First Submitted

September 26, 2025

First Posted

October 3, 2025

Study Start

January 1, 2022

Primary Completion

July 22, 2025

Study Completion

September 22, 2025

Last Updated

October 3, 2025

Record last verified: 2025-09

Locations